PALO ALTO, CA, Transcripta Bio, an AI-powered drug discovery company focused on neurological and neuromuscular diseases, announced it has raised $24 million since its Series A.
Continue Reading
Sign up for FREE to read the full article and access 147K+ alternative investment headlines.